Imvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
28 sept. 2020 09h00 HE
|
Imvaq Therapeutics
NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Imvaq Therapeutics Corp., an innovative cancer immunotherapy company founded by world-leading researchers at Memorial Sloan Kettering Cancer Center...